An EUO defense that was precluded

Understanding EUO Timing Requirements: When Insurance Companies Lose Their Defense

In New York’s no-fault insurance system, insurance companies have powerful tools to investigate potentially fraudulent claims, including the ability to require Examinations Under Oath (EUOs). However, these tools come with strict procedural requirements that must be followed precisely. When insurance companies fail to meet these deadlines, they can lose important defenses entirely.

The timing of EUO scheduling letters is particularly critical in no-fault cases. Insurance companies must act promptly after receiving claims, and courts have consistently enforced these timing requirements across New York’s appellate departments. This creates a strategic opportunity for healthcare providers and other no-fault claimants when insurance companies miss these crucial deadlines.

Understanding when EUO objections may be futile versus when timing defenses are available can significantly impact case strategy and settlement negotiations. The case of St. Locher Medical, P.C. v IDS Property Casualty Insurance Co. provides a clear example of how timing violations can completely eliminate an insurer’s EUO defense, regardless of the merits of the underlying claim.

Case Background

St. Locher Medical, P.C. provided healthcare services to an injured patient and submitted no-fault claim forms to IDS Property Casualty Insurance Company seeking reimbursement. After receiving these claims, IDS decided to investigate further by scheduling an Examination Under Oath of the patient. However, the insurance company did not act with the speed required by New York law and regulations.

According to IDS’s own submissions, the company sent the first EUO scheduling letter more than 30 days after receiving the claims from St. Locher Medical. This delay proved fatal to IDS’s defense. When the patient allegedly failed to appear for the scheduled EUO, IDS denied the underlying claims based on this non-appearance. St. Locher Medical then filed suit seeking payment, and IDS moved for summary judgment arguing that the EUO no-show excused its obligation to pay.

The trial court denied IDS’s motion, and the Appellate Term affirmed on appeal. The appellate court focused on the timing issue, finding that IDS had conceded—through its own evidence—that the EUO scheduling letter was untimely. This untimeliness meant that the EUO was never properly scheduled in the first place, rendering any subsequent no-show irrelevant to IDS’s payment obligations.

Jason Tenenbaum’s Analysis:

St. Locher Med., P.C. v IDS Prop. Cas. Ins. Co., 2017 NY Slip Op 50919(U)(App. Term 2d Dept. 2017)

“As plaintiff argues, defendant’s moving papers failed to establish that the first EUO scheduling letter defendant sent to plaintiff had been timely, since defendant stated that the letter was sent more than 30 days after defendant had received the claims”

Why not call and settle if you are defendant? This is the law in both the First and Second Departments.

Legal Significance

The St. Locher Medical decision reinforces a fundamental principle of New York no-fault law: insurance carriers must comply with procedural requirements, not just substantive ones. The 30-day deadline for EUO scheduling letters is not merely a suggestion or best practice—it is a mandatory requirement that carriers ignore at their peril. When carriers miss this deadline, they forfeit their right to assert EUO-based defenses entirely, regardless of whether the patient ultimately would have appeared or whether legitimate concerns about fraud existed.

This timing requirement serves important policy purposes. First, it prevents carriers from indefinitely delaying investigation while simultaneously holding claims in limbo. Healthcare providers who render services in good faith need timely resolution of their reimbursement requests. Allowing carriers to schedule EUOs months after receiving claims would enable strategic delay that could financially harm providers who depend on regular cash flow from no-fault reimbursements.

Second, the 30-day rule promotes efficient claims administration by forcing carriers to make prompt decisions about which claims warrant investigation. Rather than reflexively scheduling EUOs for all claims, carriers must quickly evaluate claims and identify those presenting genuine red flags. This promotes responsible use of the EUO tool and reduces unnecessary burdens on patients who must take time from work and other responsibilities to attend examinations.

Third, as Jason Tenenbaum observes, the consistency of this rule across both the First and Second Departments creates uniformity in New York no-fault practice. Healthcare providers in different parts of the state can rely on the same timing standards, simplifying compliance and reducing geographic disparities in how no-fault claims are handled. This uniformity also makes settlement negotiations more predictable—when carriers miss the 30-day deadline, both sides know the EUO defense is unavailable, facilitating efficient resolution without protracted litigation.

Practical Implications

For insurance carriers, this decision underscores the absolute importance of systematic claims review procedures. Carriers should implement tracking systems that flag newly received claims and calculate the 30-day deadline for EUO scheduling letters. When claims arrive, carriers must immediately evaluate whether an EUO is warranted and, if so, send scheduling letters well within the 30-day window. Waiting until day 29 or 30 creates unnecessary risk that minor administrative delays might cause the letter to be sent or documented as sent after the deadline expires.

Carriers should also recognize, as Jason Tenenbaum notes, that once they miss the 30-day deadline, settlement becomes the only viable option. Attempting to litigate EUO defenses that are clearly time-barred wastes resources and damages carrier credibility with courts. When carrier files reveal untimely EUO scheduling, defense counsel should promptly evaluate settlement rather than proceeding with motions that courts will inevitably deny.

For healthcare providers and their attorneys, this case provides a powerful tool for challenging EUO-based denials. When carriers assert that patients failed to appear for EUOs, providers should immediately examine the timeline between claim submission and EUO scheduling letter dates. Any gap exceeding 30 days renders the EUO defense invalid. Providers should highlight such timing violations in their complaints and opposition papers, as they often provide grounds for summary judgment in the provider’s favor.

Additionally, providers should maintain detailed records of when they submitted claims to carriers. While carriers typically bear the burden of proving timely EUO scheduling, having independent evidence of claim submission dates strengthens providers’ arguments that the 30-day window was violated. This evidence might include certified mail receipts, clearinghouse submission reports, or internal tracking logs showing when claims were transmitted.

Key Takeaway

When insurance companies fail to send EUO scheduling letters within 30 days of receiving claims, their EUO defense may be completely precluded. This timing requirement is consistently enforced across New York’s appellate departments, creating settlement leverage for plaintiffs. Unlike situations involving EUO no-shows where discovery may be waived, timing violations offer a more straightforward path to victory for healthcare providers pursuing no-fault claims. Insurance carriers must implement rigorous procedures to ensure EUO letters are sent within 30 days, and providers should carefully scrutinize timing when facing EUO-based denials.

Related Articles

• 65-3.5(b) discussed in the EUO context
• EUO no-show – correct statement of law
• Timely EUO denial